Cerus Corp (CERS) Stock Price, Quote & News

Company Profile

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company also offers INTERCEPT Blood Systems for platelets plasma, and cryoprecipitation, which is designed to inactivat...

Industry: Medical Devices

Sector: Healthcare

Phone: 925 288 6000

Website: www.cerus.com

Address:

1220 Concord Avenue, Suite 600, Concord, United States

CowboyReed May. 2 at 10:03 AM

$CERS Report this fucking spammer disgusting

0 · Reply

CowboyReed May. 2 at 10:02 AM

$CERS

0 · Reply

IAmGandalfTheWhite May. 1 at 10:25 PM

Ticker AMS🚨 top watch for next week. Looking beautiful right now. I think we are going to wake up to $4+ Monday on AMS. The setup on AMS is looking hot, float is just 3M and getting locked! $GME $CHSN $CTNT $CERS ..1127

0 · Reply

Mungman May. 1 at 9:56 PM

$CERS This stock has Legs im thinking

0 · Reply

topstockalerts May. 1 at 9:30 PM

$CERS this one’s acting different today… in a good way

0 · Reply

LukeSkywalkers May. 1 at 8:24 PM

Keep ticker AMS 🚨 on high watch, All eyes are on AMS right now!! AMS has $28M revenue and trades at a $8.5M market cap. That’s 0.30x P/S. $FFIE had zero revenue when it ran 4,000%. Book value on AMS is $3.66 per share. Stock is at $1.6 . You are buying a dollar for 32 cents. I believe AMS can be the next big runner, best to be early bulls! $BOOM $DRCT $CERS $FIVN ..,1211

0 · Reply

LuckyBagger May. 1 at 7:34 PM

$CERS going up again

0 · Reply

Nrvisions May. 1 at 7:13 PM

$CERS

0 · Reply

RETAlerts May. 1 at 6:37 PM

$CERS float rotation was crisp before this +7.3% move. Setup was there for those watching the tape close.

0 · Reply

MoneyFairyBlessings May. 1 at 6:22 PM

$CERS BUY.

0 · Reply

Cerus Earnings Call Transcript: Q1 2026

Apr 30, 2026, 4:01 PM EDT - 1 day ago

Cerus Corporation Announces First Quarter 2026 Financial Results

Apr 27, 2026, 8:00 AM EDT - 5 days ago

Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System

Apr 16, 2026, 4:01 PM EDT - 15 days ago

Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026

Mar 16, 2026, 4:05 PM EDT - 6 weeks ago

Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer

Mar 3, 2026, 10:30 AM EST - 2 months ago

Cerus Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 4:30 PM EST - 2 months ago

Cerus Earnings Call Transcript: Q4 2025

Mar 2, 2026, 4:01 PM EST - 2 months ago

Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results

Feb 20, 2026, 8:30 AM EST - 2 months ago

Cerus Corporation to Participate in the TD Cowen 46th Annual Health Care Conference

Feb 17, 2026, 4:01 PM EST - 2 months ago

Cerus Corporation to Release Fourth Quarter and Full-Year 2025 Financial Results on March 2, 2026

Jan 22, 2026, 7:30 AM EST - 3 months ago

DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus' INTERCEPT™ Blood System in Routine Clinical Practice

Jan 11, 2026, 4:00 PM EST - 3 months ago

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2025 Product Revenue and Provides Outlook

Dec 10, 2025, 4:15 PM EST - 5 months ago

Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America

Nov 6, 2025, 4:30 PM EST - 6 months ago

Cerus Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:01 PM EST - 6 months ago

Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance

Oct 21, 2025, 8:30 AM EDT - 6 months ago

Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting

Oct 16, 2025, 4:00 PM EDT - 7 months ago

Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025

Sep 3, 2025, 10:55 AM EDT - 8 months ago

Cerus Transcript: Cantor Global Healthcare Conference 2025

Aug 25, 2025, 9:00 AM EDT - 8 months ago

The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions

Aug 21, 2025, 8:30 AM EDT - 9 months ago

Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025

Aug 5, 2025, 4:30 PM EDT - 9 months ago

Cerus Earnings Call Transcript: Q2 2025

Aug 5, 2025, 4:01 PM EDT - 9 months ago

Cerus Corporation Announces Second Quarter 2025 Financial Results

Jul 22, 2025, 4:15 PM EDT - 10 months ago

Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025

Jul 21, 2025, 8:30 AM EDT - 10 months ago

Cerus Corporation Announces Additional Department of Defense Award to Advance Care for Major Hemorrhage in Traumatic Injury

Jul 2, 2025, 8:30 AM EDT - 10 months ago

Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update

Jun 13, 2025, 4:01 PM EDT - 11 months ago

Cerus Corporation Celebrates World Blood Donor Day 2025

Jun 11, 2025, 8:40 AM EDT - 11 months ago

Cerus Transcript: Goldman Sachs 46th Annual Global Healthcare Conference 2025

Jun 3, 2025, 4:30 PM EDT - 11 months ago

Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

May 29, 2025, 8:30 AM EDT - 1 year ago

Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan

May 28, 2025, 8:30 AM EDT - 1 year ago

Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 – Next-Generation INTERCEPT Illumination Device

May 1, 2025, 4:30 PM EDT - 1 year ago

Cerus Earnings Call Transcript: Q1 2025

May 1, 2025, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces First Quarter 2025 Financial Results

Apr 17, 2025, 8:30 AM EDT - 1 year ago

Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025

Mar 5, 2025, 1:00 PM EST - 1 year ago

Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)

Mar 5, 2025, 11:10 AM EST - 1 year ago

Cerus Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 20, 2025, 4:30 PM EST - 1 year ago

Cerus Earnings Call Transcript: Q4 2024

Feb 20, 2025, 4:00 PM EST - 1 year ago

Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results

Feb 19, 2025, 4:00 PM EST - 1 year ago

Cerus Corporation to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 7, 2025, 8:30 AM EST - 1 year ago

Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025

Jan 13, 2025, 8:30 AM EST - 1 year ago

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business Update

Nov 18, 2024, 4:10 PM EST - 1 year ago

Cerus Transcript: Stifel 2024 Healthcare Conference

Nov 13, 2024, 8:30 AM EST - 1 year ago

Cerus Corporation to Participate in Upcoming Investor Conferences

Oct 30, 2024, 4:30 PM EDT - 1 year ago

Cerus Earnings Call Transcript: Q3 2024

Oct 30, 2024, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces Third Quarter 2024 Financial Results

Oct 18, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024

Oct 18, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting

Oct 16, 2024, 5:00 PM EDT - 1 year ago

Cerus Transcript: Study Update

Oct 16, 2024, 4:00 PM EDT - 1 year ago

Cerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and Europe

Aug 1, 2024, 4:30 PM EDT - 1 year ago

Cerus Earnings Call Transcript: Q2 2024

Aug 1, 2024, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance Range

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Cerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024

Jul 2, 2024, 4:00 PM EDT - 1 year ago

Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors

Jun 21, 2024, 8:30 AM EDT - 2 years ago

Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion

Jun 14, 2024, 8:30 AM EDT - 2 years ago

Cerus Corporation Celebrates World Blood Donor Day 2024

May 22, 2024, 8:30 AM EDT - 2 years ago

Cerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor Conference

May 2, 2024, 4:30 PM EDT - 2 years ago

Cerus Earnings Call Transcript: Q1 2024

May 2, 2024, 4:00 PM EDT - 2 years ago

Cerus Corporation Announces First Quarter 2024 Financial Results

Apr 18, 2024, 8:30 AM EDT - 2 years ago

Cerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024

Mar 26, 2024, 8:30 AM EDT - 2 years ago

Cerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf Life

Mar 19, 2024, 8:00 AM EDT - 2 years ago

Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients

Mar 6, 2024, 11:10 AM EST - 2 years ago

Cerus Transcript: TD Cowen 44th Annual Health Care Conference

Mar 5, 2024, 4:30 PM EST - 2 years ago

Cerus Earnings Call Transcript: Q4 2023

Mar 5, 2024, 4:00 PM EST - 2 years ago

Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results

Feb 20, 2024, 8:30 AM EST - 2 years ago

Cerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024

Jan 8, 2024, 8:30 AM EST - 2 years ago

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update

Nov 15, 2023, 2:00 PM EST - 2 years ago

Cerus Transcript: Stephens Annual Investment Conference | NASH 2023

Nov 2, 2023, 4:30 PM EDT - 2 years ago

Cerus Earnings Call Transcript: Q3 2023

Nov 2, 2023, 4:00 PM EDT - 2 years ago

Cerus Corporation Announces Third Quarter 2023 Financial Results

Nov 1, 2023, 2:46 PM EDT - 2 years ago

Bloodbuy Announces Agreement with Cerus Corporation to Offer Pathogen Reduced Cryoprecipitated Fibrinogen Complex on its Digital Marketplace

Aug 2, 2023, 4:30 PM EDT - 2 years ago

Cerus Earnings Call Transcript: Q2 2023

May 4, 2023, 4:30 PM EDT - 3 years ago

Cerus Earnings Call Transcript: Q1 2023

Feb 28, 2023, 4:30 PM EST - 3 years ago

Cerus Earnings Call Transcript: Q4 2022

Nov 3, 2022, 7:30 AM EDT - 3 years ago

Cerus Earnings Call Transcript: Q3 2022

Aug 3, 2022, 11:06 PM EDT - 4 years ago

Cerus Earnings Call Transcript: Q2 2022

May 5, 2022, 10:44 AM EDT - 4 years ago

Cerus Earnings Call Transcript: Q1 2022

Feb 22, 2022, 12:55 PM EST - 4 years ago

Cerus Earnings Call Transcript: Q4 2021

CowboyReed May. 2 at 10:03 AM

$CERS Report this fucking spammer disgusting

0 · Reply

CowboyReed May. 2 at 10:02 AM

$CERS

0 · Reply

IAmGandalfTheWhite May. 1 at 10:25 PM

0 · Reply

Mungman May. 1 at 9:56 PM

$CERS This stock has Legs im thinking

0 · Reply

topstockalerts May. 1 at 9:30 PM

$CERS this one’s acting different today… in a good way

0 · Reply

LukeSkywalkers May. 1 at 8:24 PM

0 · Reply

LuckyBagger May. 1 at 7:34 PM

$CERS going up again

0 · Reply

Nrvisions May. 1 at 7:13 PM

$CERS

0 · Reply

RETAlerts May. 1 at 6:37 PM

$CERS float rotation was crisp before this +7.3% move. Setup was there for those watching the tape close.

0 · Reply

MoneyFairyBlessings May. 1 at 6:22 PM

$CERS BUY.

0 · Reply

TheBlackPearls May. 1 at 6:03 PM

Keep ticker AMS ✅on high watch, this can breakout any moment!! AMS has $28M revenue and trades at a $8.5M market cap. That’s 0.30x P/S. $FFIE had zero revenue when it ran 4,000%. Book value on AMSis $3.66 per share. Stock is at $1.6 . You are buying a dollar for 32 cents. I believe AMS can be the next big runner, best to be early bulls! $CHSN $SOBR $CERS $ORSH 12...12

0 · Reply

Stocksqueezee May. 1 at 3:53 PM

$CERS 1$$ gogo^^

1 · Reply

amersa May. 1 at 3:52 PM

$CERS I don’t know how people see negativity. Technically its very bullish, targets 3.15 - 3.89 - 4.57 as long as market positive and yes it is.

0 · Reply

Stocksqueezee May. 1 at 3:45 PM

$CERS 1$$ gogo^^

0 · Reply

erd3312 May. 1 at 3:43 PM

$CERS 2.50 is holding. I'm out

0 · Reply

marquesr1 May. 1 at 3:41 PM

$CERS I like easy money

0 · Reply

IAmGandalfTheWhite May. 1 at 3:28 PM

0 · Reply

DayTrade_4Life May. 1 at 3:24 PM

So far this Week & this Morning: Join Us for the fun. 💪 FROM WEEKLY WATCHLIST 27 Apr to 1 May: AKAN: $12 to 78.90 (557%) ATOM.X: 7.55 to 10.90 (40%) 💰FROM TODAY’s WATCHLIST & ALERTS 1 MAY: AIOS: 11.25 to 27.51 (144%) SOBR: .68 to 1.26 (85%) CUE: 24.50 to 35.88 (46%) $XXII: 2.50 to 3.55 (42%) $TLIH: 3.25 to 4.61 (41%) $AKAN: $56 to $78.90 (40%) $LABT: 3.75 to 4.65 (24%) $CERS: 2.55 to 3.15 (23%)

0 · Reply

erd3312 May. 1 at 3:15 PM

$CERS going down to 2.30 unless we reclaim 2.60. Then to 1.90. If you're long right now, you should sell. Learn from my mistakes or you'll be holding.

0 · Reply

erd3312 May. 1 at 3:04 PM

$CERS 2.60 breaks we're going to 2.30

0 · Reply

erd3312 May. 1 at 3:03 PM

$CERS she's a runner she's a track star

0 · Reply

TCLutz May. 1 at 3:00 PM

$OSRH FLASH Shot up to .90. Pulled back to .45 And now stable at .65 $815M licensing deal + forced $15M share sell @ $10 means it is significantly undervalued. $AIOS $TLIH $CERS $SPY

1 · Reply

Market Cap	406.75M
Revenue (ttm)	233.80M
Net Income (ttm)	-15.63M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-6.69%
Debt to Equity Ratio	1.29

Volume	24,834,400
Avg Vol	2,113,308
Day's Range	N/A - N/A
Shares Out	200.37M
Stochastic %K	67%
Beta	1.63
Analysts	Sell
Price Target	$5.00